Ray KK - Search Results

1

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. Among authors: ray kk. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.

2

Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology.

Ray KK, Cannon CP. Ray KK, et al. Curr Opin Lipidol. 2004 Dec;15(6):637-43. doi: 10.1097/00041433-200412000-00003. Curr Opin Lipidol. 2004. PMID: 15529022 Review.

3

Pathological changes in acute coronary syndromes: the role of statin therapy in the modulation of inflammation, endothelial function and coagulation.

Ray KK, Cannon CP. Ray KK, et al. J Thromb Thrombolysis. 2004 Oct;18(2):89-101. doi: 10.1007/s11239-004-0205-9. J Thromb Thrombolysis. 2004. PMID: 15789175 Review.

4

Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trials.

Ray KK, Cannon CP. Ray KK, et al. Expert Opin Pharmacother. 2005 Jun;6(6):915-27. doi: 10.1517/14656566.6.6.915. Expert Opin Pharmacother. 2005. PMID: 15952920 Review.

5

C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial).

Moghbeli N, Kirtane AJ, Ray KK, Murphy SA, Gibson CM, Braunwald E, Cannon CP; TIMI Study Group. Moghbeli N, et al. Among authors: ray kk. Am J Cardiol. 2005 Sep 1;96(5):635-8. doi: 10.1016/j.amjcard.2005.04.033. Am J Cardiol. 2005. PMID: 16125484

6

Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?

Ray KK, Cannon CP. Ray KK, et al. Am J Cardiol. 2005 Sep 5;96(5A):54F-60F. doi: 10.1016/j.amjcard.2005.06.027. Am J Cardiol. 2005. PMID: 16126024 Review.

7

Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.

Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E; PROVE IT-TIMI 22 Investigators. Ray KK, et al. J Am Coll Cardiol. 2005 Oct 18;46(8):1405-10. doi: 10.1016/j.jacc.2005.03.077. J Am Coll Cardiol. 2005. PMID: 16226162 Free article. Clinical Trial.

8

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.

Wiviott SD, Cannon CP, Morrow DA, Ray KK, Pfeffer MA, Braunwald E; PROVE IT-TIMI 22 Investigators. Wiviott SD, et al. Among authors: ray kk. J Am Coll Cardiol. 2005 Oct 18;46(8):1411-6. doi: 10.1016/j.jacc.2005.04.064. J Am Coll Cardiol. 2005. PMID: 16226163 Free article.

9

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.

Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E; PROVE IT-TIMI 22 Investigators. Ray KK, et al. J Am Coll Cardiol. 2005 Oct 18;46(8):1417-24. doi: 10.1016/j.jacc.2005.08.024. J Am Coll Cardiol. 2005. PMID: 16226164 Free article. Clinical Trial.

10

The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes.

Ray KK, Cannon CP. Ray KK, et al. J Am Coll Cardiol. 2005 Oct 18;46(8):1425-33. doi: 10.1016/j.jacc.2005.05.086. J Am Coll Cardiol. 2005. PMID: 16226165 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page